Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions

BACKGROUND: Elevation of liver enzymes in rheumatoid arthritis patients treated with tocilizumab (Actemra(®)) or anakinra (Kineret(®)) is a well-documented phenomenon. However, characterization of liver histology has not been defined in most cases. Similarly, the factors involved in decisions regard...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahamid, Mahmud, Mader, Reuven, Safadi, Rifaat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262392/
https://www.ncbi.nlm.nih.gov/pubmed/22287855
http://dx.doi.org/10.2147/CPAA.S24004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262392/
https://www.ncbi.nlm.nih.gov/pubmed/22287855
http://dx.doi.org/10.2147/CPAA.S24004

Ejemplares similares